Myoclonus in childhood

Seminars in Pediatric Neurology

Volumn 10, Issue 1, 2003, Pages 41-51

  Pranzatelli, Michael R ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ACETAZOLAMIDE; AZATHIOPRINE; BACLOFEN; BENZODIAZEPINE; BIOTIN; CARBIDOPA; CARNITINE; CLONAZEPAM; CORTICOTROPIN; CYCLOPHOSPHAMIDE; ESTROGEN; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; IMMUNOGLOBULIN; LAMOTRIGINE; LORAZEPAM; METHOTREXATE; NITRAZEPAM; PHENOBARBITAL; PREGABALIN; PRIMIDONE; TOPIRAMATE; TRIHEXYPHENIDYL; UBIQUINONE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CHILD; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DROWSINESS; DRUG POTENTIATION; EPILEPSY; FETUS MOVEMENT; HICCUP; HUMAN; IMMUNOTHERAPY; LABORATORY TEST; MOTOR DYSFUNCTION; MUSCLE CRAMP; MYOCLONUS; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEURORADIOLOGY; PATHOPHYSIOLOGY; PLASMAPHERESIS; REM SLEEP; REVIEW; SIDE EFFECT;

EID: 0037648463     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9091(02)00008-6     Document Type: Review

References (85)

1. Marsden CD, Hallett M, Fahn S: The nosology and pathophysiology of myoclonus, in Marsden CD, Fahn S (eds): Movement Disorders. London, Butterworths, 1982, pp 196-248
2. Pranzatelli MR: Myoclonic disorders. Pediatr Ann 22:33-37, 1993
3. Tassinari CA, Rubboli G, Parmeggiani L, et al: Epileptic negative myoclonus. Adv Neurol 67:181-197, 1995
4. Hallett M: Myoclonus: Relation to epilepsy. Epilepsia 26:567-577, 1985
5. Anstead M: Pediatric sleep disorders: New developments and evolving understanding. Curr Opin Pulm Med 6:501-506, 2000
6. Toro C, Pascual-Leone A, Deuschl G, et al: Cortical tremor: A common manifestation of cortical myoclonus. Neurology 43:2346-2352, 1993
7. DiFazio MP, Morales J, Davis R: Acute myoclonus secondary to group A beta-hemolytic streptococcus infection: A PANDAS variant. J Child Neurol 13:516-518, 1998
8. Maiteh M, Daoud AS: Myoclonic seizure following intravenous verapamil injection: Case report and review of the literature. Ann Trop Paediatr 21:271-272, 2001
9. Grech V, Vella C, Mercieca V: Temporary myoclonus with treatment of congenital transcobalamin 2 deficiency. Pediatr Neurol 24:75-76, 2001
10. Ozer EA, Turker M, Bakiler AR, et al: Involuntary movements in infantile cobalamin deficiency appearing after treatment. Pediatr Neurol 25:81-83, 2001
11. McClain BC, Probst LA, Pinter E: Intravenous clonidine use in a neonate experiencing opioid-induced myoclonus. Anesthesiology 95:549-550, 2001
12. Mercadante S, Villari P, Fulfaro F: Gabapentin for opioid-related myoclonus in cancer patients. Support Care Cancer 9:205-206, 2001
13. Zaw W, Knoppert DC, da Silva O: Flumazenil's reversal of myoclonic-like movements associated with midazolam in term newborns. Pharmacotherapy 21:642-646, 2001
14. Ghaziuddin N, Iqbal A, Khetarpal S: Myoclonus during prolonged treatment with sertraline in an adolescent patient. J Child Adolesc Psychopharmacol 11:199-202, 2001
15. Daoust-Roy J, Seshia SS: Benign neonatal sleep myoclonus: A differential diagnosis of neonatal seizures. AJDC 146:1236-1241, 1992
16. Bye AM, Kok DJ, Ferenschild FT, et al: Paroxysmal non-epileptic events in children: A retrospective study over a period of 10 years. J Paediatr Child Health 36:244-248, 2000
17. Maydell BV, Berenson F, Rothern AD, et al: Benign myoclonus of early infancy: An imitator of West's syndrome. J Child Neurol 16:109-112, 2001
18. Rajakumar K, Bodensteiner JB: Febrile myoclonus: A survey of pediatric neurologists. Clin Pediatr (Phila) 35:331-332, 1996
19. Pranzatelli MR: Paraneoplastic syndromes: An unsolved murder. Semin Pediatr Neurol 7:118-130, 2000
20. Pranzatelli MR, Tate E, Huang Y, et al: The neurophar-macology of progressive myoclonus epilepsy: Response to 5-hydroxy-L-tryptophan. Epilepsia 36:783-791, 1995
21. Berkovic SF, Carpenter S, Evans A, et al: Myoclonus epilepsy and ragged-red fibres (MERRF), 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 112(pt 5):1231-1260, 1989
22. Yoshimura I, Kaneko S, Yoshimura N, et al: Long-term observations of two siblings with Lafora disease treated with zonisamide. Epilepsy Res 46:283-287, 2001
23. Tobimatsu S, Fukui R, Shibasaki H, et al: Electrophysiological studies of myoclonus in sialidosis type 2. Clin Neurophysiol 60:16-22, 1985
24. Tomoda A, Ikezawa M, Ohtani Y, et al: Progressive myoclonus epilepsy: Dentato-rubro-pallido-luysian atrophy (DRPLA) in childhood. Brain Dev 13:266-269, 1991
25. Minassian BA, Sainz J, Delgado-Escueta AV: Genetics of myoclonus and myoclonus epilepsies. Clin Neurosci 3:223-235, 1995
26. Delgado-Escueta AV, Medine MT, Serratosa JM, et al: Mapping and positional cloning of common idiopathic generalized epilepsies: Juvenile myoclonus epilepsy and childhood absence epilepsy. Adv Neurol 79:351-374, 1999
27. Pranzatelli MR: Infantile spasms vs. myoclonus: Is there a connection?, in Schwartzkroin PA, Rho JM (eds): Epilepsy, Infantile Spasms, and Developmental Encephalopathy. San Diego, Academic Press, 2002, pp 285-314
28. Fejerman N: Myoclonus and epilepsies. Indian J Pediatr 64:583-602, 1997
29. Oguni H, Fukuyama Y, Tanaka T, et al: Myoclonicastatic epilepsy of early childhood: Clinical and EEG analysis of myoclonic-astatic seizures, and discussions on the nosology of the syndrome. Brain Dev 23:757-764, 2001
30. Pagani F, Buratti E, Stuani C, et al: A new type of mutation carries a splicing defect in ATM. Nat Genet 30:426-429, 2002
31. Klein C, Schilling K, Saunders-Pullman RJ, et al: A major focus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 67:1314-1319, 2000
32. Pranzatelli MR: Serotonin and human myoclonus: Rationale for the use of serotonin receptor agonists and antagonists. Arch Neurol 51:605-617, 1994
33. Shibasaki H: Electrophysiological studies of myoclonus. Muscle Nerve 23:321-335, 2000
34. Baumgartner C, Podreka I, Olbrich A, et al: Epileptic negative myoclonus: An EEG-single-photon emission CT study indicating involvement of premotor cortex. Neurology 46:753-758, 1996
35. Pranzatelli MR, Nadi NS: Mechanism of action of anti-epileptic and antimyoclonic drugs. Adv Neurol 67:329-360, 1995
36. Pennacchio LA, Lehesjoki AE, Stone NE, et al: Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271:1731-1734, 1996
37. Gupta P, Sajombo AA, Atashband A, et al: Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A 98:13566-13571, 2001
38. Wallace DC: Animal models for mitochondrial disease. Methods Mol Biol 197:3-54, 2002
39. Cooper JD, Gupta P, Bihle E, et al: Profound loss of GABAergic interneurons in the PPT1 knockout mouse model of infantile neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol 28:158-159, 2002
40. Chattopadhyay S, Ito M, Cooper JD, et al: An autoantibody inhibitory to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Hum Mol Genet 11:1421-1431, 2002
41. Espinosa F, McMahon A, Chan E, et al: Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3. J Neurol Sci 21:6657-6665, 2001
42. Shibasaki H, Ikeda A, Nagamino T, et al: Cortical reflex negative myoclonus. Brain 117:477-486, 1994
43. Guerrini R, De Lorey TM, Bonanni P, et al: Cortical myoclonus in Angelman syndrome. Ann Neurol 40:39-48, 1996
44. Guerrini R, Bonanni P, Patrignani A, et al: Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2. Brain 124(pt 12):2459-2475, 2001
45. Oguro K, Kobayashi J, Aiba H, et al: Opsoclonus-myoclonus syndrome with abnormal single photon emission computed tomography imaging. Pediatr Neurol 16:334-336, 1997
46. Tanaka S, Osari S, Ozawa M, et al: Recurrent pain attacks in a 3-year-old patient with myoclonus epilepsy associated with ragged-red fibers (MERRF): A single-photon emission computed tomographic (SPECT) and electrophysiological study. Brain Dev 19:205-208, 1997
47. Gascon GG, Ozand PT, Brismar J: Movement disorders in childhood organic acidurias: Clinical, neuroimaging, and biochemical correlations. Brain Dev 16(suppl):94-103, 1994
48. Hyland K, Arnold LA, Trugman JM: Defects of biopterin metabolism and biogenic amine biosynthesis: Clinical, diagnostic, and therapeutic aspects, in Fahn S, Marsden CD, DeLong M (eds): Dystonia 3: Advances in Neurology, Vol 78. Philadelphia, Lippincott-Raven, 1998, pp 301-308
49. Schols L, Gispert S, Vorgerd M, et al: Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds. Arch Neurol 54:1073-1080, 1997
50. Bespalova IN, Adkins S, Pranzatelli, M, et al: Novel cystatin B mutation and diagnostic PCR assay in Unverricht-Lundborg (Baltic) progressive myoclonus epilepsy patient. Am J Med Genet (Neuropsych Gen) 74:467-471, 1997
51. Serratosa JM, Gomez-Garre P, Gallaredo ME, et al: A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8:345-352, 1999
52. Larson GP, Ding S, Lafrenier RG, et al: Instability of the EPM1 minisatellite. Hum Mol Genet 8:1985-1988, 1999
53. Borner GV, Zeviani M, Tiranti V, et al: Decreased aminoacylation of mutant tRNAs in MELAS but not in MERRF patients. Hum Mol Genet 9:467-475, 2000
54. Wisniewski KE, Kida E, Connell F, et al: Neuronal ceroid lipofuscinoses: Research update. Neurol Sci 21(suppl 3):549-556, 2000
55. Bonten EJ, Arts WF, Beck M, et al: Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis. Hum Mol Genet 9:2715-2725, 2000
56. Wood JD, Nucifara FC, Duan K, et al: Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription. J Cell Biol 150:939-948, 2000
57. Pshezhetsky AV, Ashmarina M: Lysosomal multienzyme complex: Biochemistry, genetics and molecular pathophysiology. Prog Nucleic Acid Res Mol Biol 69:81-114, 2001
58. Minassian BA: Lafora's disease: Towards a clinical, pathologic, and molecular synthesis. Pediatr Neurol 25:21-29, 2001
59. Zimprich A, Grabowski M, Asmus F, et al: Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29:66-69, 2001
60. Tate E, Pranzatelli MR, Ho H, et al: A sensitive and semi-quantitative pediatric myoclonus evaluation scale. Neurosci Nurs 27:287-291, 1995
61. Pranzatelli MR, Tate ED, Galvan I, et al: Controlled pilot study of piracetam for pediatric opsoclonus-myoclonus. Clin Neuropharmacol 24:352-357, 2001
62. Capovilla G, Beccaria F, Veggiotti P, et al: Ethosuximide is effective in the treatment of epileptic negative myoclonus in childhood partial epilepsy. J Child Neurol 14:395-400, 1999
63. Moretti R, Torre P, Antonello RM: Opsoclonus-myoclonus syndrome: Gabapentin as a new therapeutic proposal. Eur J Neurol 7:455-456, 2000
64. Wallace SJ: Newer antiepileptic drugs: Advantages and disadvantages. Brain Dev 23:277-283, 2001
65. Eldridge R, Iivanainen M, Stern R, et al: "Baltic" myoclonus epilepsy: Hereditary disorder of childhood made worse by phenytoin. Lancet 9:838-842, 1983
66. Marciani MG, Maschio M, Spanedda F, et al: Development of myoclonus in patients with partial epilepsy during treatment with vigabatrin: An electroencephalographic study. Acta Neurol Scand 91:1-5, 1995
67. Guerrini R, Belmonte A, Parmeggiani L, et al: Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 21:420-424, 1999
68. Nanba Y, Maegaki Y: Epileptic negative myoclonus induced by carbamazepine in a child with BECTS: Benign childhood epilepsy with centrotemporal spikes. Pediatr Neurol 21:664-667, 1999
69. Asconape J, Diedrich A, DellaBadia J: Myoclonus associated with the use of gabapentin. Epilepsia 41:479-481, 2000
70. Janszky J, Rasonyi G, Halasz P, et al: Disabling erratic myoclonus during lamotrigine therapy with high serum level: Report of two cases. Clin Neuropharmacol 23:86-89, 2000
71. Huppertz HJ, Feuerstein TJ, Schulze-Bonhage A: Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia 42:790-792, 2001
72. Yiu VW, Kovithavongs T, McGonigle LF, et al: Plasmapheresis as an effective treatment for opsoclonus-myoclonus syndrome. Pediatr Neurol 24:72-74, 2001
73. Kompoliti K: Estrogen and movement disorders. Clin Neuropharmacol 22:318-326, 1999
74. Gouliaev AH, Senning A: Piracetam and other structurally related nootropics. Brain Res Rev 19:180-222, 1994
75. Ikeda A, Shibasaki H, Tashiro K, et al: Clinical trial of piracetam in patients with myoclonus: Nationwide multiinstitution study in Japan. Mov Disord 11:691-700, 1996
76. Genton P, Van Vleymen B: Piracetam and levetiracetam: Close structural similarities but different pharmacological and clinical profiles. Epileptic Disord 2:99-105, 2000
77. Feddi M, Reutens D, Dubeau F, et al: Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy. Arch Neurol 58:781-786, 2001
78. Krauss GL, Bergin A, Kramer RE, et al: Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 56:411-412, 2001
79. Pranzatelli MR, Tate ED: Chloral hydrate for progressive myoclonus epilepsy: A new look at an old drug. Pediatr Neurol 25:385-389, 2001
80. Awaad Y, Tayem H, Elgamal A, et al: Treatment of childhood myoclonus with botulinum toxin type A. J Child Neurol 14:781-786, 1999
81. Chen, R: Studies of human motor physiology with transcranial magnetic stimulation. Muscle Nerve Suppl 9, S26-S32, 2000
82. Amassian VE, Cracco RQ, Maccabee PS, et al: Some positive effects of transcranial magnetic stimulation. Adv Neurol 67:79-104, 1995
83. Triggs WJ, Kirshner HS: Improving brain function with transcranial magnetic stimulation. Neurology 56:429-430, 2001
84. McDonald WM, Greenberg BD: Electroconvulsive therapy in the treatment of neuropsychiatric conditions and transcranial magnetic stimulation as a pathophysiological probe in neuropsychiatry. Depress Anxiety 12:135-143, 2000
85. Lisanby SH, Luber B, Sackeim HA, et al: Deliberate seizure induction with negative transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry 58:199-200, 2001